Cargando…

Successful olaparib desensitization using a novel one-day protocol

BACKGROUND: Olaparib is a revolutionary treatment for patients with ovarian and breast cancer. Currently, there is no established 1-day drug desensitization protocol for patients with olaparib type-1 hypersensitivity reactions despite well documented IgE-mediated adverse reactions occurring with ola...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Rongbo, Welch, Stephen, Roberts, Hannah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659133/ https://www.ncbi.nlm.nih.gov/pubmed/33292483 http://dx.doi.org/10.1186/s13223-020-00499-x

Ejemplares similares

Failure of a single day metronidazole desensitization protocol, and success of a modified two-day protocol in an outpatient setting
por: Cahill, Julia A., et al.
Publicado: (2021)

Successful Dabrafenib Desensitization Protocols in a Patient with Metastatic Melanoma
por: Bumbacea, Roxana Silvia, et al.
Publicado: (2022)

The first successful desensitization protocol in exenatide allergy: a case report
por: Yeğit, Osman Ozan, et al.
Publicado: (2023)

Successful Desensitization of a Patient with Rituximab Hypersensitivity
por: Ataca, Pinar, et al.
Publicado: (2015)

Recurrent Cervical Cancer Treated Successfully with Single-Agent PARP-Inhibitor, Olaparib
por: Gross, Maya, et al.
Publicado: (2022)

A successful protocol for desensitization to iron salts
por: Terzioğlu, Kadriye, et al.
Publicado: (2021)

Immediate hypersensitivity reaction followed by successful oral desensitization to ursodiol
por: Lee, Erika Yue, et al.
Publicado: (2021)

Successful desensitization to radiocontrast media in two high-risk cardiac patients
por: Al-Ahmad, Mona, et al.
Publicado: (2017)

Successful desensitization therapy for a patient with isoniazid-induced hypersensitivity pneumonia
por: Chihara, Yuichi, et al.
Publicado: (2016)

A novel outpatient desensitization protocol for recombinant human erythropoietin allergy in a pediatric patient
por: Rosa, Jaime S., et al.
Publicado: (2018)

Desensitization to Adalimumab: An Example of Repeated Desensitization to a Biological Agent
por: Demirel, Fevzi, et al.
Publicado: (2015)

Successful febuxostat desensitization in a patient with febuxostat hypersensitivity: A Malaysian experience
por: Sulaiman, Narisa, et al.
Publicado: (2017)

Successful desensitization after hypersensitivity reaction to cisplatin in a patient with nasopharyngeal carcinoma
por: Kinouchi, Arisa, et al.
Publicado: (2022)

A case of successful desensitization treatment with tepotinib after tepotinib-induced rash
por: Tamura, Tomoki, et al.
Publicado: (2023)

Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction
por: Pereira, Amanda Rocha Firmino, et al.
Publicado: (2019)

One- versus 2-day aspirin desensitization in aspirin exacerbated respiratory disease: A quality improvement project
por: Gansert, Emily, et al.
Publicado: (2023)

One hundred eighteen days on a ventilator: a COVID-19 success story against all odds
por: Chia, Germaine, et al.
Publicado: (2021)

Case series of sebelipase alfa hypersensitivity reactions and successful sebelipase alfa rapid desensitization
por: Huffaker, Michelle F., et al.
Publicado: (2019)

Successful Combination of Olaparib and (225)Ac-Dotatate in a Patient with Neuroendocrine Tumor G3 and BRCA Mutation
por: Kröcher, Anke, et al.
Publicado: (2023)

Expedited Desensitization to Canakinumab
por: Sanan, Neha, et al.
Publicado: (2020)

Olaparib-Induced Immune-Mediated Liver Injury
por: Alshelleh, Mohammad, et al.
Publicado: (2022)

Olaparib is effective for recurrent urothelial carcinoma with BRCA2 pathogenic germline mutation: first report on olaparib response in recurrent UC
por: Yang, Hong, et al.
Publicado: (2020)

Familial Success in Allergen Desensitization
por: Rowane, Marija, et al.
Publicado: (2019)

Successful desensitization in a patient with hypersensitivity to multiple insulin preparations - case report
por: Petricău, Carina, et al.
Publicado: (2021)

Successful treatment of refractory lung adenocarcinoma harboring a germline BRCA2 mutation with olaparib: A case report
por: Zhang, Li, et al.
Publicado: (2021)

Analysis of Breakthrough Reactions in 1,143 Desensitization Procedures in a Single Tertiary Hospital Using a One-Bag Desensitization Protocol
por: Kim, Hyun Hwa, et al.
Publicado: (2022)

Olaparib-induced pseudoporphyria in a patient with ovarian cancer
por: Clark, Abigale, et al.
Publicado: (2023)

Desensitization therapy using ‘Mariana Castells’ protocol in a patient with multiple autoimmune disorders- does it work?
por: Shah, Syed Raza, et al.
Publicado: (2019)

Successful Drug Desensitization to Ustekinumab in a Patient with Crohn's Disease
por: Cohen, Barrie, et al.
Publicado: (2021)

A Novel Adverse Event Associated with Olaparib Therapy in a Patient with Metastatic Breast Cancer
por: Wheelden, Megan, et al.
Publicado: (2018)

Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case report
por: Pföhler, Claudia, et al.
Publicado: (2008)

A Paragonimiasis Patient with Allergic Reaction to Praziquantel and Resistance to Triclabendazole: Successful Treatment after Desensitization to Praziquantel
por: Kyung, Sun Young, et al.
Publicado: (2011)

Successful Desensitization with Crizotinib after Crizotinib-induced Liver Injury in ROS1-rearranged Lung Adenocarcinoma
por: Ota, Takayo, et al.
Publicado: (2019)

Immunotherapy of lidocaine allergy by intravenous desensitization using IFN‐gamma from a case: Overcoming impediments using IFN‐gamma during desensitization
por: Noh, Geunwoong, et al.
Publicado: (2019)

Successful desensitization in a boy with severe cow’s milk allergy by a combination therapy using omalizumab and rush oral immunotherapy
por: Takahashi, Masaya, et al.
Publicado: (2015)

Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease
por: Bangham, Madeleine, et al.
Publicado: (2016)

Successful Caesarean Section on Ticagrelor Treatment One Day after Primary Percutaneous Coronary Intervention
por: Antonijevic, Nebojsa, et al.
Publicado: (2023)

A desensitization protocol to ganciclovir
por: Cernadas, Josefina Rodrigues, et al.
Publicado: (2014)

394 Desensitization Protocol to Methotrexate
por: Maya, Jonathan, et al.
Publicado: (2012)

Efficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein
por: Ghiringhelli, Francois, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lt9n5t6s8v7uftdi53jjf58ub7